^
Association details:
Biomarker:PBRM1 mutation + TMB-H
Cancer:Non Small Cell Lung Cancer
Drug Class:Immunotherapy
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Source:
Title:

Non‑small cell lung cancer carrying PBRM1 mutation suggests an immunologically cold phenotype leading to immunotherapy failure even with high TMB

Published date:
12/01/2022
Excerpt:
In this study, we aimed to identify gene mutations associated with immunotherapy resistance and further informed mechanisms in NSCLC….Moreover, compared with PBRM1-WT/TMB-H group, OS was worse in the PBRM1-MT/TMB-H group.
DOI:
https://doi.org/10.1038/s41598-022-25050-3